Biotech Analyst McCamant Publishes Book for Investors

'Every Investor's Guide' Seeks to Unravel Complicated Science Issues

BIOTECH by Marion Webb, Senior Staff Writer

James McCamant, editor of the Medical Technology Stock Letter in Berkeley, has had his hand on biotechnology's heartbeat since biochemist Herbert Boyer teamed up with venture capitalist Robert Swanson to start the South San Francisco biotech giant Genentech Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99